Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice

Abstract

An international group of HS experts and PRPs achieved consensus on a core set of HS measures suitable for use in clinical practice. Consistent use of these measures may lead to more accurate assessments of HS disease activity and life outcomes, facilitating shared treatment decision-making in the practice setting.